Cefazolin Dosing for Cellulitis in Adults
For hospitalized adults with nonpurulent cellulitis, administer cefazolin 1 gram IV every 8 hours for moderate-to-severe infections, with treatment duration of 5-7 days based on clinical response.
Standard Dosing Regimen
The FDA-approved dosing for moderate-to-severe infections is 500 mg to 1 gram every 6 to 8 hours 1. For cellulitis specifically:
- Moderate-to-severe cellulitis: 1 gram IV every 8 hours is the most commonly used regimen
- Mild cellulitis: 500 mg every 8 hours may be sufficient
- Maximum daily dose: Up to 12 grams daily in rare instances for severe infections 1
The IDSA guidelines support using cefazolin as a β-lactam option for hospitalized patients with nonpurulent cellulitis (cellulitis without purulent drainage or abscess), with modification to MRSA-active therapy only if there is no clinical response 2, 3, 2. This is a critical distinction—cefazolin should NOT be used empirically for purulent cellulitis where MRSA coverage is needed.
Special Populations
Obese Patients (≥120 kg)
Recent evidence suggests 3 grams every 8-12 hours for patients weighing ≥120 kg provides better outcomes. A 2025 study demonstrated a 63.7% probability of better outcomes with 3-gram dosing compared to standard doses in patients ≥120 kg 4. This higher dose compensates for altered pharmacokinetics in obesity.
Renal Impairment
Dosing adjustments are essential 1:
- CrCl ≥55 mL/min: Full dose every 8 hours
- CrCl 35-54 mL/min: Full dose but extend interval to every 8 hours minimum
- CrCl 11-34 mL/min: Half the usual dose every 12 hours (after loading dose)
- CrCl ≤10 mL/min: Half the usual dose every 18-24 hours (after loading dose)
Always give an appropriate loading dose based on infection severity before implementing reduced dosing.
Treatment Duration
5-7 days is recommended for most cases of cellulitis 5, 6. The 2014 IDSA guidelines specifically state that 5 days is adequate, with extension only if the infection has not improved 5. This is supported by randomized controlled trial data showing no difference in outcomes between 5 and 10 days of therapy 2.
For hospitalized patients with complicated SSTI, 7-14 days may be needed, individualized based on clinical response 2, 3, 2.
Alternative Outpatient Regimens
For patients suitable for home-based therapy:
- Cefazolin 2 grams IV twice daily: Well-tolerated and effective, with clinical cure rates of 88-96% 7
- Cefazolin 2 grams IV once daily PLUS probenecid 1 gram PO once daily: Equivalent efficacy to ceftriaxone (86% cure rate), though associated with more nausea 8, 9
The once-daily regimen with probenecid maintains therapeutic trough levels (median 2.35 mcg/mL) by blocking renal tubular secretion 8.
Critical Caveats
MRSA Coverage: Cefazolin has NO activity against MRSA. If purulent drainage, systemic toxicity, or failure to respond to β-lactam therapy occurs, switch immediately to vancomycin, linezolid, daptomycin, or another MRSA-active agent 2, 3, 2.
Streptococcal Coverage: Cefazolin provides excellent coverage for β-hemolytic streptococci (the primary pathogen in nonpurulent cellulitis), making it ideal first-line therapy in this setting 5, 6.
Peripheral IV Tolerance: Recent data show cefazolin elastomeric infusers via peripheral IV are well-tolerated with 88.3% having no complications (VIP score = 0), making outpatient therapy feasible 10.
Pharmacokinetic Considerations: Cefazolin achieves peak serum concentrations of approximately 185 mcg/mL after 1 gram IV, with a half-life of 1.8 hours. The every-8-hour dosing interval maintains concentrations above the MIC for susceptible organisms throughout the dosing interval 1.